Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$2.50M
50.56K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 50.56K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $2.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/25/2026ACC: 0001950047-26-008670
Officer· Chief Development Officer
Since Feb 2026
50.56K
Shares to sell
$2.50M
Approx. market value
37K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
6/9/2024
37KTotal acquired37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/9/2024 | Founders Shares N/A | 37K | — |
| Total | 37K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
13.16K
Market value
$658.0K
8/24/2026
—Completed
Units to sell
404.00
Market value
$20.2K
8/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
37K
Market value
$1.83M
8/25/2026
Total
Units
50.56K
Value
$2.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/24/2026 | 13.16K | $658.0K | — | Completed |
8/19/2026 | 404.00 | $20.2K | — | Completed |
| Planned — Approximate Date | ||||
8/25/2026 | 37K | $1.83M | NASDAQ | Planned |
| Total | 50.56K | $2.50M | ||